phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with amphetamine in 3 studies
| Studies (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Trials (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Recent Studies (post-2010) (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Studies (amphetamine) | Trials (amphetamine) | Recent Studies (post-2010) (amphetamine) |
|---|---|---|---|---|---|
| 276 | 0 | 55 | 13,071 | 329 | 1,977 |
| Protein | Taxonomy | phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide (IC50) | amphetamine (IC50) |
|---|---|---|---|
| Phenylethanolamine N-methyltransferase | Bos taurus (cattle) | 0.96 | |
| Cytochrome P450 2A6 | Homo sapiens (human) | 3.5 | |
| Cytochrome P450 2A5 | Mus musculus (house mouse) | 2.85 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.96 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.96 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JC; Huang, YK; Li, JY; Liang, KW | 1 |
| Chen, JC; Chen, PC; Huang, EY; Lee, WH; Tseng, CP | 1 |
| Gibula-Bruzda, E; Koltunowska, D; Kotlinska, JH; Raoof, H; Silberring, J; Suder, P | 1 |
3 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and amphetamine
| Article | Year |
|---|---|
Neuropeptide FF potentiates the behavioral sensitization to amphetamine and alters the levels of neurotransmitters in the medial prefrontal cortex.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Dopamine; Drug Synergism; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Motor Activity; Narcotic Antagonists; Neurotransmitter Agents; Nucleus Accumbens; Oligopeptides; Prefrontal Cortex; Random Allocation; Rats; Rats, Sprague-Dawley; Serotonin; Substance-Related Disorders | 1999 |
Rat NPFF(1) receptor-mediated signaling: functional comparison of neuropeptide FF (NPFF), FMRFamide and PFR(Tic)amide.
Topics: Adenylyl Cyclases; Amphetamine; Analgesia; Animals; Colforsin; Dopamine and cAMP-Regulated Phosphoprotein 32; FMRFamide; Injections, Intraventricular; Injections, Spinal; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Motor Activity; Neuropeptides; Oligopeptides; p38 Mitogen-Activated Protein Kinases; PC12 Cells; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide; Signal Transduction; Tetrahydroisoquinolines | 2006 |
Modulation of neuropeptide FF (NPFF) receptors influences the expression of amphetamine-induced conditioned place preference and amphetamine withdrawal anxiety-like behavior in rats.
Topics: Adamantane; Amphetamine; Animals; Anxiety; Behavior, Animal; Conditioning, Psychological; Dipeptides; Dose-Response Relationship, Drug; Male; Maze Learning; Oligopeptides; Rats; Rats, Wistar; Receptors, Neuropeptide; Substance Withdrawal Syndrome | 2012 |